In summary, our results demonstrate that miR-133a-3p inhibits bone metastasis of PCa by targeting multiple cytokine receptors, including EGFR, FGFR1, IGF1R and MET, leading to inactivation of PI3K/AKT signaling pathway. The gene discussed is MET; the disease is posterior cortical atrophy.